Intrinsic Value of S&P & Nasdaq Contact Us

Veradigm Inc. MDRX OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
57/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.17
+260.1%

Veradigm Inc. (MDRX) has a consensus analyst rating of Hold, based on 43 analysts covering the stock. Of those, 16 recommend buying, 24 recommend holding, and 3 recommend selling.

The analyst consensus price target for MDRX is $16.17, representing a +260.1% upside from the current price of $4.49. Price targets range from a low of $10.00 to a high of $20.00.

Analyst Consensus — MDRX

Hold
Strong Buy
1
Buy
15
Hold
24
Sell
2
Strong Sell
1
43 analysts
Price Targets
Consensus$16.17
High$20.00
Low$10.00
Median$18.50
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message